![](https://visionhealth.gmbh/wp-content/uploads/2023/02/Neuer-Investor-1-300x240.png)
VisionHealth raises 3 million Euro to finance extended COPD and asthma study
VisionHealth raises 3 million Euro to finance extended COPD and asthma study for market preparation of Kata®, an innovative digital therapeutic for improved inhalation DB Speciality Invest, an investment firm of Dr. Dietrich Bruchmann, invests in VisionHealth Funds will be used for EU and U.S. regulatory approval and commercial launch